Why Integrative Therapies?
Over the past few months, I have found myself becoming uncomfortable with using the term complementary therapies to describe the range of therapies that are part of what is being called integrative medicine. The term integrative therapies, as used in the title of this journal, has a very different connotation than CAM practice.
In this regard, my experience at the recent Society for Integrative Oncology meeting, held in early November in San Diego, California, brought some of these thoughts into sharper focus. A concept brought up by one speaker (and referred to by others) to describe the role of various types of therapies in integrative medicine was "feel better, live better, get better." Therapies such as massage, yoga, stress reduction techniques, or strategies to reduce the side effects of conventional treatment seem to be classified under the "feel better" concept, with a suggestion that some things that make you feel better (such as antioxidants during cancer therapies) are somewhat inimical to getting better. Under "live better," one could put the lifestyle therapies such as dietary changes and exercise, useful in their own right in terms of general improvement of health. However, this speaker felt that under the "get better" classification, only conventional therapies should be included. Thus, "complementary" therapies are placed in the "feel better" and "live better" categories but excluded from the "get better" category. Alternative therapies were excluded from the fold altogether, on the grounds that they simply do not work. Much of this classification is based on the lack of large-scale randomized, controlled trials that demonstrate that the various complementary therapies are able to prolong life after a cancer diagnosis.
This concept is, exactly, what is causing my discomfort with the term complementary therapies. The therapies often termed complementary should not, I feel, be excluded from the process of getting cancer patients "better." It is true that they can certainly be conceived of and used in a way that relegates them to nice, but perhaps not necessary, ways of improving quality of life (which is a wonderful goal, certainly, but definitely not the only one sought by most cancer patients with lifethreatening disease). In true integrative care, the complementary therapies are viewed and used specifically as means to contribute to the overall process of "getting better," or at least maximizing the length of optimal-quality life as much as possible. For instance, Michelle Holmes (a very effective speaker at the Society meeting) recently analyzed prospective data from the Nurses' Health Study on women who had stages I to III breast cancer. She reports that women who performed exercise equivalent to 3 to 5 hours a week of walking at a normal pace were only 50% as likely to die as were women who exercised less than 3 hours a week. 1 While exercise would be classified under "living better," it seems to me that this is a potentially very large contribution to "getting better" with several good side effects (better sleep, better weight control, less depression) and few negative ones (the occasional minor sports injury). If a new drug was found to reduce breast cancer mortality by 50% in early-stage studies, we can be sure that the publicity surrounding it would be deafening, which has not yet been the case with the results of Holmes.
But say a patient has painful muscle contractions or strains from cancer-related anxiety or from improper exercise technique, which hinder her psychologically or physically from exercising. Addressing these through regular massage, yoga classes, or physical therapy may enable her to exercise more effectively and regularly, which then may contribute to her "getting better." In this situation, complementary therapies are part of a continuum of therapies, all of which aim at getting the patient better. Therapies such as massage or yoga are not, frankly, ever likely to go through large-scale randomized trials that show they can contribute to increased survival through this continuum. Does that mean they have no part in getting patients better? On the contrary, they may indeed play a critical role in allowing the patient to continue exercising and thus ultimately contribute to survival.
This example is just one of many possible illustrations of how therapies usually termed complementary or even alternative may contribute to getting cancer patients better, if they are used strategically as part of a comprehensive program to improve the survival, as well as the survivorship, of cancer patients. The name of this journal, Integrative Cancer Therapies, is thus in some ways a statement of our editorial position: the therapies discussed in these pages are ones that have, or may have, the potential to contribute to improving survival as well as quality of life of cancer patients, if they are integrated into a comprehensive and scientifically based program adapted to the needs of the patient's disease, stage, and biological and social individuality. The individual therapies themselves may or Editorial may not make direct contributions to survival, but the fact that the contributions of some therapies are indirect does not lessen their importance.
Sometimes one of the most important contributions that integrative therapies can make is to simply keep patients in their treatments. There are times when this contribution cannot be overestimated. In this issue, we are pleased to present our first pediatric Integrative Tumor Board, authored by Dr Kara Kelly and other members of the Integrative Therapies Program for Children With Cancer and the Herbert Irving Child and Adolescent Oncology Center of Columbia University Medical Center. Linda Granowetter, Elena Ladas, Kathy Taromina, and Diane Rooney discuss the treatment of a pediatric patient with synovial sarcoma of the jaw from the perspectives of oncology, nutrition, acupuncture, traditional Chinese medicine, massage therapy, and integrative medicine. A major thrust of the integrative treatments received by this patient was to allow him to cope with the physical challenges engendered by his rigorous conventional treatment regimen. The discussions of how this group, and the patient's family, met the difficulties of administering a whole foods-based diet to a child using a gastrostomy tube and the detailed descriptions of the use of massage therapy (including intraoral massage) and reflexology in dealing with the impact of conventional treatment are areas that have not appeared in previous Tumor Boards and thus are of particular interest. Columbia has been very active in the area of pediatric integrative oncology, and the contributions to this Tumor Board demonstrate the scope of this involvement.
As we are putting together this issue, however, a news item puts the importance of Columbia's efforts into even sharper perspective. A young teen in Texas was diagnosed with Hodgkin lymphoma in January 2005. After undergoing planned chemotherapy, a change in protocol was recommended to include radiation therapy, despite what her parents understood as improved scans. 2 Within 2 weeks, 3 radiation oncologists gave the parents different treatment recommendations as well as alarming descriptions of potential late sequelae of radiation therapy. The parents, who had been expressing interest in nutrition and alternative treatments as well as prayer healing, asked for a fourth opinion to help clarify confusing recommendations. Three days later, before access to the fourth opinion was granted, social workers began threatening to contact the state's child protective services agency to enforce a treatment recommendation due to medical neglect on the part of the parents, apparently because of this request. Soon after, the state took custody of the child and placed her with a foster family distant from her parents. She underwent further evaluation and conventional treatment (which did not include radiation therapy) under the guardianship of the foster family for 5 months. The child was eventually returned to her parents with recurrent disease and poor prognosis and is now undergoing treatment with intravenous high-dose vitamin C in a Kansas clinic, chosen by the parents during the time she was away from home, with a radiation oncologist involved in her case, although to date there still has been no decision about radiation treatment. The obvious stress on the patient from this action on the part of the state has to be viewed with alarm, to say the least.
Besides illustrating the dire consequences of poor communication between medical professionals and patients, this case highlights the critical need for true integrative care in the pediatric oncology arena. This is certainly not the first case in which parents have had legal difficulties resulting from their interest in alternative treatments for children with cancer. Rather than entering into an adversarial relationship with parents who are obviously interested in alternatives (although they willingly accepted initial recommendations for chemotherapy), the integrative approach would incorporate all levels of healing, from the chemical to the spiritual, into the treatment of the patient. Integrative interventions relevant to this case might have included incorporating nutritional treatments and spiritual healing, discussing potential lifestyle changes that have at least theoretical bearing on decreasing long-term radiotherapy sequelae, working with the individual patient and family to develop a treatment plan that is both medically and personally acceptable, and incorporation of alternative treatments that are safe and have some scientific rationale 3 at an appropriate place in the overall treatment approach. This would have done this patient much more good than governmental enforcement of conventional protocols. This is certainly the type of case in which the use of integrative therapies has the potential to maintain a patient in a productive conventional treatment paradigm, as well as to address needs for long-term physical and emotional health. While both integrative and strictly conventional physicians need to work continuously and consciously on communications skills, integrative physicians may have an advantage over those opposed to integrative approaches in a case of this type. It is less likely that integrative practitioners will be perceived as being negative and rejecting health considerations that are of major importance to the family and patient. We look forward to an accelerating pace of research in integrative pediatric oncology, such as the work of Dr Kelly and her colleagues at Columbia and elsewhere, and to the day when incidents such as this Texas debacle are a thing of the past.
An unusual article in this issue, by Michael McCulloch and colleagues, approaches cancer diagnosis in an intriguing way. Based on case reports of dogs alerting their owners to the presence of cancers by showing apparent concern when sniffing skin lesions, a new field of investigation has arisen in the past 15 years: canine scent detection of cancer. A recent publication in BMJ, for instance, established proof of principle of canine detection of bladder cancer by sniffing urine samples. 4 Melanoma detection has also been studied in the labs of Dr James Walker in Florida. 5 The study by McCulloch et al in this issue explores whether dogs can be trained to detect a difference in breath samples given by breast and lung cancer patients versus samples given by control (breath samples were captured in a vapor-sampling apparatus; patients were never sniffed by dogs directly). The theory behind these studies is that cancers, as well as normal tissues, release a complex mixture of volatile organic compounds. Some of the volatile compounds characteristic of cancer have been detected by chemical analysis, such as gas chromatography/mass spectroscopy (GCMS), but the chemical methods are too crude to detect the range of different compounds that might be given off by cancers in contrast to normal tissues. Dogs, however, have long been known for having stunningly sensitive olfactory capacity. And as intelligent animals, they can be trained to discriminate between scents of different types, possibly taking into account a complex mixture of compounds by integrating a range of information that would be difficult to program into a GCMS analysis. McCulloch and colleagues report that dogs can be trained to detect lung and breast cancer samples with surprisingly high sensitivity and specificity. While this methodology is obviously not yet ready for clinical application and would be indicated to supplement rather than replace other diagnostic methods, I see this study as one more indication of the useful medical guidance we can glean from paying close attention to the capacities of the natural world, as well as, of course, a real delight to dog owners everywhere.
We are pleased to announce in this issue the addition of Ralph W. Moss, PhD, to our editorial staff in the position of corresponding editor. Moss has contributed interesting accounts of alternative cancer therapies in Italy and Mexico, as well as the alternative cytoluminescent therapy to the pages of Integrative Cancer Therapies in the past. We are enthused to have Dr Moss join our staff. He will continue to submit articles that add a fascinating and very useful dimension to what we are able to offer our readers. In this issue, he offers an analysis of a well-publicized critique of the antioxidant-chemotherapy controversy, published by Gabriella D'Andrea, MD, 6 in late 2005, pointing out that there is considerably less to this critique than may appear at first glance.
We are also pleased to present a thorough review of the antiangiogenic properties of natural supplements by herbalist Donald Yance, an Editorial Consultant for this journal, and radiation oncologist Stephen Sagar, MD, a member of our Editorial Board. In this review, the introductory discussion of the role of angiogenesis and antiangiogenic medications in cancer therapy is notable for its clarity and definitely is suggested reading for practitioners who wish to increase the depth of their understanding of this area. The review is also notable for integrating the insights of an herbalist along with those of a radiation oncologist-certainly one of the more interesting combinations of expertise we have recently seen-and for the respect with which herbalist information is used in the discussion of various issues.
This issue also features a case series study by Stanislaw Burzynski, MD, PhD, and colleagues on the use of antineoplastons in high-grade or recurrent brainstem gliomas. The patients in this study were participants who were found to have this particular pathology in 4 of the phase 2 clinical trials that are being conducted at the Burzynski clinic. In addition, we have a case report of a pancreatic cancer patient whose disease has been stabilized for more than 3 years using a treatment incorporating a-lipoic acid, low-dose naltrexone, an antioxidant supplement, and an integrative diet. This case study was written up by Drs Burton Berkson and Aurthur Berkson, along with our assistant editor Dan Rubin. While studies of cases and case series are certainly not as highly ranked in evidence-based assessments as randomized trials, they are legitimate scientific observations and as such are one of the foundations of medical progress. We are looking forward to continued progress in the scientific work of these authors.
This issue also features a description of the integrative oncology program of the UCLA Center for East-West Medicine submitted by Ka-Kit Hui, MD, and colleagues. The UCLA program is based on the insights of traditional Chinese medicine, incorporating other therapies such as massage and trigger point injection as well. The case studies in this report, which feature the clinical use of massage, acupuncture, and trigger point therapies in cancer patients, are of particular interest.
Finally, we would like to thank the following external reviewers who assisted our internal review staff in the process of selecting manuscripts for publications during 2005: Richard Blitstein, LAc, MSTOM; Penny Block, MA; Joan Faier-Routman, PhD; Mark McCarty; Mark Meyers, MS; Guido Pauli, PhD; James Villano, MD; and James Walker, PhD. We are most grateful to these reviewers for their critical contributions to the soundness of the scientific work in our journal and with this listing recognize their valuable efforts.
